{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T19:51:10Z","timestamp":1778529070910,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jmii.2023.08.003","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T22:24:25Z","timestamp":1691533465000},"page":"1105-1113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of mycophenolic acid with cyclophosphamide for the treatment of pediatric lupus nephritis: A retrospective study from a tertiary center hospital in Taiwan"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0147-6620","authenticated-orcid":false,"given":"Huei-Geng","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Shuen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Ching","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Hsuan","family":"Chiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jmii.2023.08.003_bib1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0961203311412096","article-title":"Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus","volume":"20","author":"Pineles","year":"2011","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.jmii.2023.08.003_bib2","first-page":"776","article-title":"Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan","volume":"22","author":"Huang","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.pcl.2012.03.007","article-title":"Systemic lupus erythematosus in children and adolescents","volume":"59","author":"Levy","year":"2012","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib4","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/2175-8239-jbn-2018-0097","article-title":"Pediatric lupus nephritis","volume":"41","author":"Pinheiro","year":"2019","journal-title":"J Bras Nefrol"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.003_bib5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.rdc.2013.05.001","article-title":"Biomarkers and updates on pediatrics lupus nephritis","volume":"39","author":"Bennett","year":"2013","journal-title":"Rheum Dis Clin N Am"},{"issue":"7","key":"10.1016\/j.jmii.2023.08.003_bib6","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/art.30350","article-title":"End-stage renal disease due to lupus nephritis among children in the US, 1995-2006","volume":"63","author":"Hiraki","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jmii.2023.08.003_bib7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.jmii.2023.08.003_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198603063141004","article-title":"Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs","volume":"314","author":"Austin","year":"1986","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jmii.2023.08.003_bib9","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa043731","article-title":"Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis","volume":"353","author":"Ginzler","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5527\/wjn.v3.i2.16","article-title":"Pediatric lupus nephritis: management update","volume":"3","author":"Sinha","year":"2014","journal-title":"World J Nephrol"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.003_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"American College of Rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.jmii.2023.08.003_bib12","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/0961203320931567","article-title":"Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis","volume":"29","author":"Romano-Aguilar","year":"2020","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.003_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1440-1797.2007.00862.x","article-title":"Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis","volume":"13","author":"Mak","year":"2008","journal-title":"Nephrology (Carlton)."},{"issue":"38","key":"10.1016\/j.jmii.2023.08.003_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022328","article-title":"Comparative efficacy and safety of mycophenolate mofetil and cyclophosphamide in the induction treatment of lupus nephritis: a systematic review and meta-analysis","volume":"99","author":"Jiang","year":"2020","journal-title":"Medicine (Baltim)"},{"issue":"1","key":"10.1016\/j.jmii.2023.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000120","article-title":"A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience","volume":"3","author":"Anutrakulchai","year":"2016","journal-title":"Lupus Sci Med"},{"issue":"8","key":"10.1016\/j.jmii.2023.08.003_bib16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1177\/0961203308090991","article-title":"Efficacy of enteric-coated mycophenolate sodium in patients with resistant-type lupus nephritis: a prospective study","volume":"17","author":"Traitanon","year":"2008","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib17","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1600-6143.2003.00337.x","article-title":"Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients","volume":"4","author":"Salvadori","year":"2004","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.003_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trre.2012.02.001","article-title":"Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing","volume":"26","author":"Cooper","year":"2012","journal-title":"Transplant Rev (Orlando)"},{"issue":"11","key":"10.1016\/j.jmii.2023.08.003_bib19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1523-1755.2004.00443.x","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"65","author":"Weening","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.jmii.2023.08.003_bib21","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"issue":"7","key":"10.1016\/j.jmii.2023.08.003_bib22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1651-2227.2010.01771.x","article-title":"Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis","volume":"99","author":"Marks","year":"2010","journal-title":"Acta Paediatr"},{"issue":"3","key":"10.1016\/j.jmii.2023.08.003_bib23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.jmii.2023.08.003_bib24","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/acr.23215","article-title":"Comparative effectiveness of mycophenolate mofetil for the treatment of juvenile-onset proliferative lupus nephritis","volume":"69","author":"Tian","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"5","key":"10.1016\/j.jmii.2023.08.003_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/0961203319836712","article-title":"Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis","volume":"28","author":"Smith","year":"2019","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.jmii.2023.08.003_bib26","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/art.10461","article-title":"Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide","volume":"46","author":"Houssiau","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jmii.2023.08.003_bib27","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3899\/jrheum.210428","article-title":"Use of EuroLupus cyclophosphamide dosing for the treatment of lupus nephritis in childhood-onset systemic lupus erythematosus in north America","volume":"49","author":"Cannon","year":"2022","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jmii.2023.08.003_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2165\/00003495-200363020-00004","article-title":"Newer drugs for the treatment of lupus nephritis","volume":"63","author":"Kuiper-Geertsma","year":"2003","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.jmii.2023.08.003_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.4103\/1319-2442.215147","article-title":"Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: which is better? A single-center experience","volume":"28","author":"Mendonca","year":"2017","journal-title":"Saudi J Kidney Dis Transpl"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118223001536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:31:05Z","timestamp":1761658265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118223001536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S1684118223001536"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2023.08.003","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of mycophenolic acid with cyclophosphamide for the treatment of pediatric lupus nephritis: A retrospective study from a tertiary center hospital in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2023.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}